Related Experiment Videos
Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice
Abstract:
The role of macrophages in the difference in liver pathogenicity between herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in mice was investigated by selectively blocking the macrophage function of the mice by silica. Intravenous administration of 3 mg of silica 2 h before virus inoculation partially abolished the difference between the two virus types, as judged by macroscopic and microscopic examination of the livers and by virus isolation studies. Intraperitoneal inoculation of 50 mg of silical before virus seemed more effective in suppressing the macrophage function, since this treatment almost completely eliminated the difference in hepatotropism between HSV-1 and HSV-2 as assessed by the number and size of the lesions appearing in the liver. The final outcome of the infection, death from encephalitis, was, however, not influenced by macrophage blockade.
Insights
Macrophages influence liver disease severity between herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in mice. Blocking macrophage function with silica reduced liver damage but did not affect encephalitis-related death.
Area of Science:
- Virology
- Immunology
- Pathology
Background:
- Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) exhibit different liver pathogenicity in mice.
- Macrophages are key immune cells involved in host defense against viral infections.
Purpose of the Study:
- To investigate the role of macrophages in the differential liver pathogenicity of HSV-1 and HSV-2 in a mouse model.
- To determine if modulating macrophage function affects the outcome of HSV infection in the liver.
Main Methods:
- Selective blockade of macrophage function using silica administration (intravenous and intraperitoneal) in mice.
- Inoculation with HSV-1 or HSV-2.
- Macroscopic and microscopic examination of liver tissues.
- Virus isolation studies.
- Assessment of clinical outcomes, including encephalitis and death.
Main Results:
- Silica administration partially abolished the difference in liver pathogenicity between HSV-1 and HSV-2 when given intravenously.
- Intraperitoneal silica administration was more effective, nearly eliminating the difference in hepatotropism (liver tropism) between the two virus types.
- Macrophage blockade did not influence the final outcome of the infection, specifically death from encephalitis.
Conclusions:
- Macrophages play a significant role in the differential liver pathogenicity observed between HSV-1 and HSV-2 in mice.
- Targeting macrophage function can modulate the severity of HSV-induced liver disease.
- The role of macrophages in HSV-induced encephalitis and mortality appears distinct from their role in liver pathogenesis.